FDA Approves Genentech’s Avastin® (Bevacizumab) Plus Chemotherapy for a Specific Type of Advanced Ovarian Cancer Approval based on two large Phase III studies including GOG-0213 that showed a five month overall survival difference for women with platinum-sensitive recurrent ovarian cancer on Avastin plus chemotherapy compared to chemotherapy alone In the [..]
Learning words from pictures System correlates recorded speech with images, could lead to fully automated speech recognition. Larry Hardesty | MIT News Office December 7, 2016 Speech recognition systems, such as those that convert speech to text on cellphones, are generally the result of machine learning. A computer pores through [..]
Pfizer Announces Expansion of ASPIRE Awards Program for 2017 to Include $5.5M in Funding for Breast and Hematologic Cancers 2016 ASPIRE Breast Cancer Research Award Winners Also Unveiled December 7, 2016 Pfizer News Pfizer Inc. (NYSE:PFE) today announced that it will expand the company’s Advancing Science through Pfizer Investigator [..]
Stanford Unveils Innovative Solar Generating Station Leading the way in sustainability and innovative green technologies, Stanford celebrated the opening of the Stanford Solar Generating Station in Kern County, Calif. The station will provide more than 50 percent of Stanford’s electricity. DECEMBER 5, 2016 Leading the way in sustainability and innovative [..]
A More Energy Efficient New Memory Technology By Stanford Scientists While exploring the atomic-level forces at play in a new type of computer chip, researchers found an energy-saving surprise that could translate into longer battery life for next-generation mobile devices. By : TOM ABATE (Stanford News) Scientists often discover interesting [..]
Parkinson’s Disease Linked to Microbiome By Lori Dajose (CALTECH News) Caltech scientists have discovered for the first time a functional link between bacteria in the intestines and Parkinson’s disease (PD). The researchers show that changes in the composition of gut bacterial populations—or possibly gut bacteria themselves—are actively contributing to and [..]
FDA Approves Nivolumab for Head and Neck Cancer By: NCI Staff December 5, 2016 The Food and Drug Administration (FDA) approved nivolumab (Opdivo®) on November 10 for the treatment of squamous cell cancer of the head and neck (SCCHN). Nivolumab is already approved for the treatment of several other cancers. [..]
New interim data demonstrate Sandoz proposed biosimilar rituximab has equivalent efficacy to reference product ASSIST-FL trial demonstrates equivalent safety, efficacy, pharmacokinetics and pharmacodynamics of Sandoz proposed biosimilar rituximab (GP2013) to the reference product[1] Interim data in over 600 adults show potential of GP2013 as an alternative rituximab[1] Sandoz proposed biosimilar [..]
Novartis data shows Treatment-free Remission rates are consistently above 50% regardless of reason for switch to Tasigna® from Glivec® ENESTop post-hoc analysis provides further insights into Treatment-free Remission (TFR) among Ph+ CML switch patients[1] The Tasigna TFR trials, including ENESTop, demonstrate our continued commitment to the CML community By: Novertis [..]
Design your own custom drone CSAIL system lets users design and fabricate drones with a wide range of shapes and structures. By: Adam Conner-Simons | CSAIL (MIT NEWS) December 5, 2016 This fall’s new Federal Aviation Administration regulations have made drone flight easier than ever for both companies and consumers. But [..]
Novartis presents results from first global registration trial of CTL019 in pediatric and young adult patients with r/r B-ALL 82% (41 of 50) of patients achieved complete remission or complete remission with incomplete blood count recovery in interim analysis of Novartis study (ELIANA) ELIANA, the first global CAR T cell [..]
Genentech’s Gazyva Helped People With Previously Untreated Follicular Lymphoma Live Significantly Longer without their Disease Worsening Compared to Rituxan First Phase III study to show superior progression-free survival compared to Rituxan-based standard of care treatment for most common slow-growing form of non-Hodgkin’s lymphom Results will be presented during the Plenary [..]
Portions of the brain fall asleep and wake back up all the time, Stanford researchers find New research finds that small regions of the brain cycle in and out of sleep, even when awake. The cycles shift toward “awake” when that part of the brain pays attention to a task. [..]
Global Entrepreneurship Summit 2017 3rd-5thFebruary, 2017 Click here to know registration procedure Visit our 2016 website 00
IoT Evolution Expo January 7-10, 2017, Fort Lauderdale, FL The IoT Evolution Expo, organized by the IoT Evolution Expo will take place from 7th January to 10th January 2017 in Fort Lauderdale, United States Of America. The conference will cover areas like Machine-to-machine (M2M) communications, Microprocessor/microcontroller choices, IoT for Automotive, [..]
Startup World Cup 2017 Startup World Cup is a global conference and competition that brings together the top startups, VCs, entrepreneurs and world-class tech CEOs. They are partnering with some of world’s largest conferences and tech events to host 16 regional startup competitions for North & South America, Europe, Asia, [..]
A Hydrogel That Helps Stop Uncontrolled Bleeding Works in patients on blood thinners or with bleeding disorders By Benjamin Boettner, Wyss Institute Communications Small blood clots called emboli are mostly known for traveling through the vasculature before they lodge and obstruct vessels, impeding blood and oxygen supply to organs such [..]
New Nontoxic Hydrogels : Aid in Food Production and Other Applications Hydrogels already form the absorbent layer in disposable diapers and the curve of soft contact lenses. A new process makes these materials useful for more applications, including wine-making and firefighting. BY GLEN MARTIN (Stanford News) Hydrogels are gelatinous amalgams [..]
Novartis SEG101 (crizanlizumab, formerly SelG1) significantly reduces frequency of sickle cell pain crises in Phase II study SEG101 reduced annual rate of sickle cell-related pain crises (SCPC) by 45.3% compared to placebo in patients with or without hydroxyurea therapy SEG101 is a potential new disease-modifying, preventive treatment option for [..]
New Phase 2 Results Show Investigational Compound Glasdegib Improved Overall Survival in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome Data on First Smoothened Inhibitor to Show Clinical Benefit in This Patient Population to be Presented During Oral Session at 2016 ASH Annual Meeting December 3, 2016 Today, Pfizer [..]
Computer Learns to Recognize Sounds by Watching Video Machine-learning system doesn’t require costly hand-annotated data. Larry Hardesty | MIT News Office December 3, 2016 In recent years, computers have gotten remarkably good at recognizing speech and images: Think of the dictation software on most cellphones, or the algorithms [..]
A radiation-free approach to imaging molecules in the brain New probe induces blood flow changes that can be seen by MRI. Anne Trafton | MIT News Office December 3, 2016 Scientists hoping to get a glimpse of molecules that control brain activity have devised a new probe that [..]
Relvar® Ellipta® 100/25 mcg gains approval in Japan for use in patients with COPD 02 December 2016 GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Relvar® Ellipta®(fluticasone furoate / vilanterol 100/25 mcg) for the relief [..]
IBM and Pfizer Collaboration to Accelerate Immuno-oncology Research with Watson for Drug Discovery Collaboration combines IBM Watson’s cognitive computing capabilities with Pfizer’s scientific knowledge to help scientists generate meaningful insights December 2, 2016 ARMONK, N.Y. and NEW YORK, Dec. 1, 2016 /PRNewswire/ — IBM (NYSE: IBM) Watson Health and [..]
LYRICA® (pregabalin) Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint By: Pfizer News December 2, 2016 Pfizer Inc. (NYSE:PFE) announced today positive top-line results of a study that evaluated the use of LYRICA® (pregabalin) Capsules CV and Oral Solution CV as adjunctive therapy for pediatric epilepsy patients four [..]
New Chemical Tool to Control Inflammation With the Help of UV Light By: Krishna Ramanujan See Also: Cornell News Black light does more than make posters glow. Cornell researchers have developed a chemical tool to control inflammation that is activated by ultraviolet (UV) light. The method will allow scientists to [..]
Bioenergy-Awards for Cutting Edge Research (B-ACER) Application submission deadline extended upto 15th December 2016 Recognizing that clean and efficient energy, environmental protection and energy security are among the biggest challenges facing India and the United States; the Department of Biotechnology, Government of India and the Indo-US Science and Technology Forum [..]
Pfizer Announces Positive Top-Line Results from the Pivotal Comparative REFLECTIONS B3271002 Study for PF-05280014, a Potential Biosimilar to Herceptin®1 (trastuzumab) Results Demonstrate Equivalence in Objective Response Rate in Patients with HER2-positive Metastatic Breast Cancer By: Pfizer Inc. November 30, 2016 Pfizer Inc. (NYSE:PFE) today announced that the pivotal REFLECTIONS B3271002 [..]
LIGO back online, ready for more discoveries Upgrades make detectors more sensitive to gravitational waves. By: Jennifer Chu | MIT News Office November 30, 2016 Today, scientists restarted the twin detectors of LIGO, the Laser Interferometer Gravitational-wave Observatory, after making several improvements to the system. Over the last [..]
Just Three Atoms Thick New Prototype Chip Created by Stanford Engineers Ever since scientists discovered that atomically thin materials could have useful electronic properties, engineers have been seeking ways to mass-produce so-called single-layer chips. A new technique shows how it might be done. By Tom Abate (Stanford NEWS) NOVEMBER 29, 2016 [..]
Copyright © 2024 | WordPress Theme by MH Themes